Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Mukuria

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Patient-Reported Outcomes|February 28, 2024
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosisClara Mukuria, Donna Rowen, Sarah Acaster, et al.
Pharmacoeconomics|August 11, 2016
Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPaul Tappenden, Sue Harnan, Shijie Ren, et al.
Value in Health Regional Issues|November 5, 2019
Valuing Health State: An EQ-5D-5L Value Set for EthiopiansAbraham G Welie, Gebremedhin Beedemariam Gebretekle, Elly Stolk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 11, 2022
Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in EthiopiaAbraham G Welie, Elly Stolk, Clara Mukuria, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ-HWBClara Mukuria, Janice Connell, Jill Carlton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Social Science & Medicine (1982)|August 15, 2022
Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off techniqueDonna Rowen, Clara Mukuria, Nathan Bray, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 12, 2013
Cost-effectiveness of an improving access to psychological therapies serviceClara Mukuria, John Brazier, Michael Barkham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2022
Author ReplyJohn Brazier, Tessa Peasgood, Clara Mukuria, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Patient-Reported Outcomes|February 28, 2024
Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosisClara Mukuria, Donna Rowen, Sarah Acaster, et al.
Pharmacoeconomics|August 11, 2016
Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPaul Tappenden, Sue Harnan, Shijie Ren, et al.
Value in Health Regional Issues|November 5, 2019
Valuing Health State: An EQ-5D-5L Value Set for EthiopiansAbraham G Welie, Gebremedhin Beedemariam Gebretekle, Elly Stolk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2023
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study ProtocolDonna Rowen, Clara Mukuria, Nathan Bray, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 11, 2022
Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in EthiopiaAbraham G Welie, Elly Stolk, Clara Mukuria, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ-HWBClara Mukuria, Janice Connell, Jill Carlton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Social Science & Medicine (1982)|August 15, 2022
Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off techniqueDonna Rowen, Clara Mukuria, Nathan Bray, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 12, 2013
Cost-effectiveness of an improving access to psychological therapies serviceClara Mukuria, John Brazier, Michael Barkham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2022
Author ReplyJohn Brazier, Tessa Peasgood, Clara Mukuria, et al.
Pageof 8